MBX Biosciences, Inc. Common Stock Financial Flexibility Index
MBX Biosciences, Inc. Common Stock financial flexibility index. MBX Biosciences, Inc. Common Stock (MBX) has a Financial Flexibility Index of -1.32x as of March 2026. Free cash flow of $-19.77 Million (operating CF $-20.21 Million minus capex $437.00K) represents -1% of total liabilities ($14.95 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MBX Biosciences, Inc. Common Stock (2022–2025)
Financial flexibility index of MBX Biosciences, Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for MBX Biosciences, Inc. Common Stock across 4 annual periods. Explore MBX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
MBX Biosciences, Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
MBX Biosciences, Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for MBX Biosciences, Inc. Common Stock. For the full cash flow conversion analysis, see MBX Biosciences, Inc. Common Stock cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.90x | $-78.02 Million | $-79.95 Million | $15.92 Million | ▼ -1.0% |
| 2024 | -4.85x | $-53.81 Million | $-54.68 Million | $11.09 Million | ▼ -2285.7% |
| 2023 | -0.20x | $-31.85 Million | $-31.98 Million | $156.65 Million | ▲ +21.4% |
| 2022 | -0.26x | $-22.68 Million | $-23.12 Million | $87.70 Million | — |